Biosynex SA (ALBIO.PA)

EUR 1.4

(0.0%)

EBITDA Summary of Biosynex SA

  • Biosynex SA's latest annual EBITDA in 2023 was -10.18 Million EUR , down -99.13% from previous year.
  • Biosynex SA's latest quarterly EBITDA in 2024 Q2 was -11.5 Million EUR , down 0.0% from previous quarter.
  • Biosynex SA reported an annual EBITDA of 46.72 Million EUR in 2022, down -62.5% from previous year.
  • Biosynex SA reported an annual EBITDA of 146.59 Million EUR in 2021, up 181.18% from previous year.
  • Biosynex SA reported a quarterly EBITDA of -14.01 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Biosynex SA reported a quarterly EBITDA of N/A for 2023 FY, down -99.13% from previous quarter.

Annual EBITDA Chart of Biosynex SA (2023 - 2009)

Historical Annual EBITDA of Biosynex SA (2023 - 2009)

Year EBITDA EBITDA Growth
2023 -10.18 Million EUR -99.13%
2022 46.72 Million EUR -62.5%
2021 146.59 Million EUR 181.18%
2020 51.29 Million EUR 3056.11%
2019 1.64 Million EUR 97.82%
2018 838.87 Thousand EUR -40.36%
2017 1.4 Million EUR 8.95%
2016 1.29 Million EUR 965.64%
2015 139.51 Thousand EUR 61.14%
2014 -1.25 Million EUR 73.87%
2013 -677.36 Thousand EUR -313.36%
2012 -445.14 Thousand EUR -73.64%
2011 -157.52 Thousand EUR -462.82%
2010 56.1 Thousand EUR 143.69%
2009 -127 Thousand EUR 0.0%

Peer EBITDA Comparison of Biosynex SA

Name EBITDA EBITDA Difference
Predilife S.A. -3.82 Million EUR -166.519%
bioMérieux S.A. 828.1 Million EUR 101.23%
Eurofins Scientific SE 1.2 Billion EUR 100.845%
Lumibird SA 27.3 Million EUR 137.292%